৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Indications: Mexclav is indicated for the treatment of infections caused by sensitive bacteria, including:
Pharyngitis/Tonsillitis caused by Streptococcus pyogenes
Acute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta‑lactamase producing strains), or Streptococcus pyogenes
Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta‑lactamase producing strains)
Lower respiratory tract infections including pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta‑lactamase producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase and non‑penicillinase producing strains), Streptococcus pyogenes, E. coli
Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta‑lactamase negative strains), or Haemophilus parainfluenzae (beta‑lactamase negative strains)
Uncomplicated skin and skin‑structure infections caused by Staphylococcus aureus (including beta‑lactamase producing strains) or Streptococcus pyogenes
Uncomplicated urinary tract infections caused by E. coli or Klebsiella pneumoniae
Bone and joint infections caused by Staphylococcus aureus (penicillinase and non‑penicillinase producing strains)
Uncomplicated gonorrhea caused by penicillinase‑producing and non‑penicillinase producing strains of Neisseria gonorrhoeae
Early Lyme disease (erythema migrans) caused by Borrelia burgdorferi
Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E. coli, Haemophilus influenzae (including ampicillin‑resistant strains), and Klebsiella spp.
Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin‑resistant strains), Neisseria meningitidis, and Staphylococcus aureus (penicillinase and non‑penicillinase producing strains)
Switch therapy (injectable to oral)
Pharmacology: Cefuroxime is a bactericidal second‑generation cephalosporin antibiotic active against a wide range of Gram‑positive and Gram‑negative organisms, including many beta‑lactamase producing strains. It inhibits bacterial cell wall synthesis by interfering with the transpeptidation process. Clavulanic acid is a naturally derived beta‑lactamase inhibitor produced by Streptomyces clavuligerus. It irreversibly binds to beta‑lactamase enzymes, inactivating them, and protects cefuroxime from degradation, enabling treatment of infections caused by beta‑lactam resistant bacteria.
Dosage & Administration:
Adolescents and adults (≥13 years):
Pharyngitis/Tonsillitis: 250 mg twice daily for 5–10 days
Acute maxillary sinusitis: 250 mg twice daily for 10 days
Acute exacerbation of chronic bronchitis: 250–500 mg twice daily for 10 days
Secondary bacterial infections of acute bronchitis: 250–500 mg twice daily for 5–10 days
Skin/skin‑structure infections: 250–500 mg twice daily for 10 days
Urinary tract infections: 250 mg twice daily for 7–10 days
Gonorrhea: 1000 mg single dose
Community‑acquired pneumonia: 250–500 mg twice daily for 5–10 days
MDR Typhoid fever: 500 mg twice daily for 10–14 days
Early Lyme disease: 500 mg twice daily for 20 days
Pediatric patients (3 months–12 years):
Pharyngitis/Tonsillitis: 20 mg/kg/day in two divided doses for 5–10 days
Acute otitis media: 30 mg/kg/day in two divided doses for 10 days
Acute maxillary sinusitis: 30 mg/kg/day in two divided doses for 10 days
Impetigo: 30 mg/kg/day in two divided doses for 10 days






Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mexclav 500 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Cefuroxime + Clavulanic Acid is a combination of two medicines: Cefuroxime and Clavulanic Acid. Cefuroxime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Clavulanic Acid is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate Cefuroxime. Addition of Clavulanic Acid reduces resistance and enhances the activity of Cefuroxime against bacteria.





